Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
54
TMRAY Quote, Financials, Valuation and Earnings
Last price:
$13.67
Seasonality move
:
0.7%
Day range:
$15.66 - $15.66
52-week range:
$12.33 - $16.94
Dividend yield:
1.33%
P/E ratio:
41.66x
P/S ratio:
3.21x
P/B ratio:
7.16x
Volume:
1.7K
Avg. volume:
1.2K
1-year change:
21.02%
Market cap:
$4.6B
Revenue:
$1.5B
EPS (TTM):
$0.38
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.3B | $1.2B | $1.4B | $1.5B | |
| Revenue Growth (YoY) | 2.1% | 19.52% | -5.37% | 14.01% | 4.61% | |
| Cost of Revenues | $416.5M | $514.6M | $507.3M | $565.7M | $588.1M | |
| Gross Profit | $664.7M | $777.7M | $715.6M | $828.6M | $870.4M | |
| Gross Profit Margin | 61.48% | 60.18% | 58.52% | 59.43% | 59.68% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $523.3M | $593.8M | $570.1M | $719.4M | $701M | |
| Operating Income | $141.4M | $183.9M | $145.5M | $109.2M | $169.4M | |
| Net Interest Expenses | $5.9M | $7M | $8.1M | $18.6M | $25.2M | |
| EBT. Incl. Unusual Items | $116.4M | $180.5M | $140.6M | $91.7M | $141.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $29.6M | $46.3M | $33.5M | $22.3M | $34.3M | |
| Net Income to Company | $116.4M | $180.5M | $140.6M | $91.7M | $141.9M | |
| Minority Interest in Earnings | -$2.5M | -$4.9M | -$3.9M | -$5M | -$6.1M | |
| Net Income to Common Excl Extra Items | $84.3M | $129.3M | $103.2M | $64.4M | $101.5M | |
| Basic EPS (Cont. Ops) | $0.29 | $0.44 | $0.35 | $0.22 | $0.35 | |
| Diluted EPS (Cont. Ops) | $0.29 | $0.44 | $0.35 | $0.22 | $0.35 | |
| Weighted Average Basic Share | $295.2M | $295.4M | $295.2M | $295.4M | $295.7M | |
| Weighted Average Diluted Share | $295.2M | $295.4M | $295.2M | $295.4M | $295.7M | |
| EBITDA | $216.6M | $288.1M | $239.4M | $213.6M | $273.7M | |
| EBIT | $122.4M | $186.8M | $148M | $108.6M | $165.9M | |
| Revenue (Reported) | $1.1B | $1.3B | $1.2B | $1.4B | $1.5B | |
| Operating Income (Reported) | $141.4M | $183.9M | $145.5M | $109.2M | $169.4M | |
| Operating Income (Adjusted) | $122.4M | $186.8M | $148M | $108.6M | $165.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $275.3M | $293.1M | $306.7M | $316.1M | $322M | |
| Revenue Growth (YoY) | 26.22% | 6.48% | 4.64% | 3.04% | 1.87% | |
| Cost of Revenues | $158.3M | $176.3M | $183.3M | $189M | $185.2M | |
| Gross Profit | $117M | $116.8M | $123.5M | $127.1M | $136.8M | |
| Gross Profit Margin | 42.49% | 39.84% | 40.26% | 40.21% | 42.48% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $95M | $94.8M | $101.3M | $116.2M | $115.7M | |
| Operating Income | $22M | $22M | $22.2M | $10.9M | $21M | |
| Net Interest Expenses | $2.7M | -- | $6.1M | $7.6M | $7.4M | |
| EBT. Incl. Unusual Items | $19.3M | $22.8M | $16.1M | $3.3M | $13.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4.8M | $5.7M | $4.1M | $1.1M | $3.2M | |
| Net Income to Company | $19.3M | $22.8M | $16.1M | $3.3M | $13.7M | |
| Minority Interest in Earnings | -$1M | -$562.7K | -$378.8K | -$1.1M | -- | |
| Net Income to Common Excl Extra Items | $13.5M | $16.6M | $11.7M | $1.1M | $10.5M | |
| Basic EPS (Cont. Ops) | $0.05 | $0.06 | $0.04 | -- | $0.03 | |
| Diluted EPS (Cont. Ops) | $0.05 | $0.06 | $0.04 | -- | $0.03 | |
| Weighted Average Basic Share | $295M | $294.2M | $295.2M | $295.5M | $333.3M | |
| Weighted Average Diluted Share | $295M | $294.2M | $295.2M | $295.5M | $333.3M | |
| EBITDA | $47.5M | $47.1M | $45.9M | $35.8M | $49.5M | |
| EBIT | $22M | $22M | $22.2M | $10.9M | $21M | |
| Revenue (Reported) | $275.3M | $293.1M | $306.7M | $316.1M | $322M | |
| Operating Income (Reported) | $22M | $22M | $22.2M | $10.9M | $21M | |
| Operating Income (Adjusted) | $22M | $22M | $22.2M | $10.9M | $21M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.3B | $1.3B | $1.4B | $1.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $438.1M | $540M | $536M | $801M | $821.3M | |
| Gross Profit | $696.9M | $770.7M | $725.7M | $593.7M | $642M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $548.3M | $587.4M | $579.2M | $496.9M | $462.5M | |
| Operating Income | $148.6M | $183.3M | $146.5M | $96.8M | $179.5M | |
| Net Interest Expenses | -- | $3.6M | $14.8M | $18.5M | $27M | |
| EBT. Incl. Unusual Items | $142M | $183.1M | $134.8M | $80.5M | $152.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $36M | $47M | $32.1M | $19.6M | $35.5M | |
| Net Income to Company | $139M | $184M | $133.9M | $78.9M | $152.3M | |
| Minority Interest in Earnings | -$4.9M | -$1.1M | -$825K | -$5.4M | -$5.4M | |
| Net Income to Common Excl Extra Items | $101.1M | $135.1M | $102M | $54.4M | $110.6M | |
| Basic EPS (Cont. Ops) | $0.35 | $0.45 | $0.33 | $0.18 | $0.38 | |
| Diluted EPS (Cont. Ops) | $0.35 | $0.45 | $0.33 | $0.18 | $0.38 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $279.3M | $339.8M | $292.6M | $204.2M | $291M | |
| EBIT | $128.7M | $186.1M | $148.9M | $98.9M | $179.5M | |
| Revenue (Reported) | $1.1B | $1.3B | $1.3B | $1.4B | $1.5B | |
| Operating Income (Reported) | $148.6M | $183.3M | $146.5M | $96.8M | $179.5M | |
| Operating Income (Adjusted) | $128.7M | $186.1M | $148.9M | $98.9M | $179.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $275.3M | $293.1M | $306.7M | $316.1M | $322M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $158.3M | $176.3M | $183.3M | $189M | $185.2M | |
| Gross Profit | $117M | $116.8M | $123.5M | $127.1M | $136.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $95M | $94.8M | $101.3M | $116.2M | $115.7M | |
| Operating Income | $22M | $22M | $22.2M | $10.9M | $21M | |
| Net Interest Expenses | $2.7M | -- | $6.1M | $7.6M | $7.4M | |
| EBT. Incl. Unusual Items | $19.3M | $22.8M | $16.1M | $3.3M | $13.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4.8M | $5.7M | $4.1M | $1.1M | $3.2M | |
| Net Income to Company | $19.3M | $22.8M | $16.1M | $3.3M | $13.7M | |
| Minority Interest in Earnings | -$1M | -$562.7K | -$378.8K | -$1.1M | -- | |
| Net Income to Common Excl Extra Items | $13.5M | $16.6M | $11.7M | $1.1M | $10.5M | |
| Basic EPS (Cont. Ops) | $0.05 | $0.06 | $0.04 | -- | $0.03 | |
| Diluted EPS (Cont. Ops) | $0.05 | $0.06 | $0.04 | -- | $0.03 | |
| Weighted Average Basic Share | $295M | $294.2M | $295.2M | $295.5M | $333.3M | |
| Weighted Average Diluted Share | $295M | $294.2M | $295.2M | $295.5M | $333.3M | |
| EBITDA | $47.5M | $47.1M | $45.9M | $35.8M | $49.5M | |
| EBIT | $22M | $22M | $22.2M | $10.9M | $21M | |
| Revenue (Reported) | $275.3M | $293.1M | $306.7M | $316.1M | $322M | |
| Operating Income (Reported) | $22M | $22M | $22.2M | $10.9M | $21M | |
| Operating Income (Adjusted) | $22M | $22M | $22.2M | $10.9M | $21M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $62.3M | $71.6M | $76.5M | $107.9M | $122M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $226.5M | $243.7M | $281.3M | $302.7M | $300.5M | |
| Inventory | $174.8M | $213.5M | $241.8M | $262.4M | $234.6M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $516.3M | $595.7M | $681.7M | $790.5M | $772.8M | |
| Property Plant And Equipment | $277.7M | $249.1M | $272.5M | $316.1M | $368.9M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $355.4M | $336.5M | $317.9M | $321.9M | $356.2M | |
| Other Intangibles | $64.6M | $65.6M | $68.4M | $74.3M | $105.1M | |
| Other Long-Term Assets | -- | $11.3K | -- | -$221.1K | -$104.1K | |
| Total Assets | $1.3B | $1.3B | $1.4B | $1.6B | $1.7B | |
| Accounts Payable | $64.8M | $73M | $67M | $81.2M | $63.9M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $30.5M | $30.2M | $29.3M | $38M | $42.7M | |
| Other Current Liabilities | $1.5M | -- | -- | -- | -- | |
| Total Current Liabilities | $307.3M | $395.1M | $359.5M | $536.1M | $547M | |
| Long-Term Debt | $165.6M | $68.4M | $223.6M | $253.5M | $322.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $630.9M | $615M | $751M | $945M | $1.1B | |
| Common Stock | $17.3M | $16.8M | $15.1M | $28.5M | $26.8M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $635.9M | $679.4M | $650.9M | $652.6M | $627.8M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $19.1M | $19.4M | $19.6M | $26.2M | $34.3M | |
| Total Equity | $655M | $698.8M | $670.5M | $678.8M | $662.1M | |
| Total Liabilities and Equity | $1.3B | $1.3B | $1.4B | $1.6B | $1.7B | |
| Cash and Short Terms | $62.3M | $71.6M | $76.5M | $107.9M | $122M | |
| Total Debt | $180.2M | $124.8M | $231.5M | $356.4M | $420.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $53.1M | $72.2M | $69.1M | $103M | $98.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $282.8M | $336M | $336.1M | $389.3M | $414.5M | |
| Inventory | $183.7M | $224M | $261.4M | $273M | $259.8M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $519.6M | $632.2M | $666.7M | $765.3M | $772.8M | |
| Property Plant And Equipment | $264.5M | $264.6M | $272.9M | $326.6M | $400.5M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.3B | $1.4B | $1.4B | $1.6B | $1.8B | |
| Accounts Payable | $66.8M | $67.6M | $55M | $61.2M | $67.1M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $202.7M | $247.7M | $213.9M | $273.3M | -- | |
| Total Current Liabilities | $328.5M | $461.8M | $409M | $523.2M | $267.3M | |
| Long-Term Debt | $152M | $87.8M | $185.3M | $257.8M | $304.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $612.4M | $649.7M | $741M | $933.1M | $1.1B | |
| Common Stock | $124.6M | $124.3M | -- | $98.5M | $647.2M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $19.5M | $20.3M | $20M | $27.4M | $37.9M | |
| Total Equity | $651M | $728.6M | $679.8M | $663.2M | $685.1M | |
| Total Liabilities and Equity | $1.3B | $1.4B | $1.4B | $1.6B | $1.8B | |
| Cash and Short Terms | $53.1M | $72.2M | $69.1M | $103M | $98.5M | |
| Total Debt | $152M | $135.6M | $211.6M | $339.3M | $373.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $116.4M | $180.5M | $140.6M | $91.7M | $141.9M | |
| Depreciation & Amoritzation | $93.6M | $100.9M | $91.4M | $97.4M | $107.2M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$5.7M | -$47.7M | -$73.6M | -$46.3M | -$19M | |
| Change in Inventories | $17.8M | -$51.6M | -$37.9M | -$17.9M | $14.8M | |
| Cash From Operations | $186M | $210.7M | $115.4M | $148.1M | $254.9M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$239.3K | $9M | -$301K | -$2.6M | -$88.3M | |
| Cash From Investing | -$58M | -$51.3M | -$76.2M | -$108M | -$214M | |
| Dividends Paid (Ex Special Dividend) | -$44.2M | -$52.5M | -$88.9M | -$49.2M | -$53.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $406.3M | $175.9M | $160.3M | $93.4M | $185.4M | |
| Long-Term Debt Repaid | -$443.4M | -$234M | -- | -$108.3K | -$33.6M | |
| Repurchase of Common Stock | -- | -- | -$12.8M | -- | -- | |
| Other Financing Activities | $10.9K | -- | -- | $4.9M | $9M | |
| Cash From Financing | -$120.1M | -$149.4M | -$19.9M | -$2.9M | -$24.4M | |
| Beginning Cash (CF) | $50M | $63M | $63.4M | $77.2M | $112.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $7.9M | $10M | $19.3M | $37.1M | $16.6M | |
| Ending Cash (CF) | $57.9M | $74.8M | $75.2M | $112.5M | $133.1M | |
| Levered Free Cash Flow | $186M | $210.7M | $115.4M | $148.1M | $254.9M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $46.5M | $31.9M | $39.5M | $35.5M | -- | |
| Depreciation & Amoritzation | $24.1M | $20.5M | $25.3M | $25.6M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$28.8M | -$30.7M | -$45.7M | -$14.1M | -- | |
| Change in Inventories | -$9.5M | -$14.8M | -$7.9M | $151.1K | -- | |
| Cash From Operations | $33.4M | $29.6M | $5.2M | $37.5M | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$12.2M | -$11.1M | -$23.3M | -$26.6M | -- | |
| Dividends Paid (Ex Special Dividend) | -$52.4M | -$94.2M | -$51.2M | -$56M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $33.2M | $86.4M | $60M | $35.5M | -- | |
| Cash From Financing | -$13.8M | -$2.3M | $13.2M | -$17.3M | -- | |
| Beginning Cash (CF) | $54.6M | $72.6M | $68.1M | $103.2M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -$9.8M | -$9.4K | -- | |
| Additions / Reductions | $7.3M | $16.2M | -$4.8M | -$6.4M | -- | |
| Ending Cash (CF) | $60.8M | $79.9M | $60M | $95.8M | -- | |
| Levered Free Cash Flow | $33.4M | $29.6M | $5.2M | $37.5M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $139M | $184M | $133.9M | $78.9M | $152.3M | |
| Depreciation & Amoritzation | $98.9M | $100.4M | $90.1M | $98.6M | $110.6M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$21.4M | -$63.2M | -$14M | -$70.2M | -$20.4M | |
| Change in Inventories | $10.2M | -$43.7M | -$46M | -$19.1M | $15.4M | |
| Cash From Operations | $193.3M | $197.8M | $144.2M | $120.5M | $302.7M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$239.3K | $9M | -$301K | -$2.6M | -$88.3M | |
| Cash From Investing | -$61.8M | -$64.8M | -$69.2M | -$124.6M | -$217M | |
| Dividends Paid (Ex Special Dividend) | -- | -$53.5M | -$89M | -$50.2M | -$51.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$11.4M | $35.4M | -$29.4M | $34.4M | -$50.2M | |
| Cash From Financing | -$131.5M | -$115M | -$49.4M | $25.5M | -$84.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$36.6K | $18M | $25.6M | $21.4M | $1.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $193.3M | $197.8M | $144.2M | $120.5M | $302.7M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $65.8M | $54.7M | $55.6M | $38.8M | $13.7M | |
| Depreciation & Amoritzation | $49.6M | $45.5M | $49.1M | $50.6M | $28.4M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$38.2M | -$55.5M | -$10.9M | -$3.2M | $9.5M | |
| Change in Inventories | -$25.3M | -$22.7M | -$24M | -$17.2M | -$16.8M | |
| Cash From Operations | $65.7M | $49M | $53.4M | $58.1M | $68.4M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$26.1M | -$38.5M | -$43.6M | -$63.5M | -$40M | |
| Dividends Paid (Ex Special Dividend) | -$52.4M | -$95.2M | -$52.3M | -$58.1M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $5.3M | $93.9M | $38.2M | $43.1M | -$51.6M | |
| Cash From Financing | -$41.7M | $4.2M | -$9.8M | -$11.8M | -$54.7M | |
| Beginning Cash (CF) | $118.5M | $146.7M | $139.1M | $216.2M | $129.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -$17.4M | $1.1M | -$7.4M | |
| Additions / Reductions | -$2.1M | $14.8M | -- | -$17.2M | -$26.3M | |
| Ending Cash (CF) | $115.4M | $152.5M | $128.1M | $199M | $95.8M | |
| Levered Free Cash Flow | $65.7M | $49M | $53.4M | $58.1M | $68.4M | |
Get TMRAY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TMRAY
Sector
P/E ratio
41.66x
18.58x
PEG ratio
0.40x
0.25x
P/B ratio
7.16x
1.75x
Price / LTM sales
3.21x
0.94x
Growth Metrics
TMRAY
Sector
Revenue growth
1.87%
1.98%
Earnings growth
460.91%
2.46%
Revenue (5-year growth)
6.61%
4.35%
Earnings forecast
--
$0.40
Profitability
TMRAY
Sector
Profitability FY 2024
$870.4M
$393.9M
Return on invested capital
10.6%
5.32%
Return on assets
6.6%
3.49%
Return on equity
16.7%
8.55%
Earnings Date
Last Earnings Date
May
7
Next Earnings Date
Jul
17
Estimated Next Earnings Date
Oct
16
Balance Sheet
TMRAY
Sector
Total cash
$98.5M
$154.3M
Short term investments
--
$35.5M
Total assets
$1.7B
$1.7B
Long term debt
$373.4M
$252.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
